Putting evidence-based medicine into clinical practice: comparing anti-resorptive agents for the treatment of osteoporosis.

PubWeight™: 2.11‹?› | Rank: Top 2%

🔗 View Article (PMID 15119990)

Published in Curr Med Res Opin on April 01, 2004

Authors

Lois E Wehren1, David Hosking, Marc C Hochberg

Author Affiliations

1: University of Maryland School of Medicine, Baltimore, MD, USA. lois_wehren@msn.com

Articles citing this

Effects of parathyroid hormone alone or in combination with antiresorptive therapy on bone mineral density and fracture risk--a meta-analysis. Osteoporos Int (2006) 1.79

Therapeutic effects of alendronate 35 mg once weekly and 5 mg once daily in Japanese patients with osteoporosis: a double-blind, randomized study. J Bone Miner Metab (2005) 1.34

Effect of osteoporosis treatments on risk of non-vertebral fractures: review and meta-analysis of intention-to-treat studies. Osteoporos Int (2005) 1.09

Effect of the cathepsin K inhibitor odanacatib administered once weekly on bone mineral density in Japanese patients with osteoporosis--a double-blind, randomized, dose-finding study. Osteoporos Int (2013) 0.85

Fracture prevention in postmenopausal women. BMJ Clin Evid (2011) 0.84

Persistence with weekly and monthly bisphosphonates among postmenopausal women: analysis of a US pharmacy claims administrative database. Clinicoecon Outcomes Res (2013) 0.80

Differences between the bisphosphonates for the prevention and treatment of osteoporosis. Ther Clin Risk Manag (2006) 0.77

Comment on Putting evidence-based medicine into clinical practice: comparing anti-resorptive agents for the treatment of osteoporosis. Curr Med Res Opin (2004) 0.75

Comment on Putting evidence-based medicine into clinical practice: comparing anti-resorptive agents for the treatment of osteoporosis. Curr Med Res Opin (2004) 0.75

Sequential multiple insufficiency fractures around knee over 6 months in a patient with primary osteoporosis. Eur J Orthop Surg Traumatol (2012) 0.75

Articles by these authors

(truncated to the top 100)

Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum (2008) 19.80

Ten years' experience with alendronate for osteoporosis in postmenopausal women. N Engl J Med (2004) 8.86

Effectiveness of acupuncture as adjunctive therapy in osteoarthritis of the knee: a randomized, controlled trial. Ann Intern Med (2004) 5.69

Prevalence of knee symptoms and radiographic and symptomatic knee osteoarthritis in African Americans and Caucasians: the Johnston County Osteoarthritis Project. J Rheumatol (2007) 5.23

Comparison of 2 frailty indexes for prediction of falls, disability, fractures, and death in older women. Arch Intern Med (2008) 5.14

Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial. Lancet (2004) 4.46

Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease. N Engl J Med (2005) 3.57

Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial. Lancet (2004) 3.57

Bone mineral density and the risk of incident nonspinal fractures in black and white women. JAMA (2005) 3.30

Frailty and risk of falls, fracture, and mortality in older women: the study of osteoporotic fractures. J Gerontol A Biol Sci Med Sci (2007) 3.16

Long-term risk of incident vertebral fractures. JAMA (2007) 3.15

Relation of physical activity time to incident disability in community dwelling adults with or at risk of knee arthritis: prospective cohort study. BMJ (2014) 3.11

A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis. Arthritis Res Ther (2008) 2.87

The risk of hospitalized infection in patients with rheumatoid arthritis. J Rheumatol (2008) 2.60

Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis. Ann Rheum Dis (2010) 2.39

Hip fracture in women without osteoporosis. J Clin Endocrinol Metab (2005) 2.35

Progression of radiographic hip osteoarthritis over eight years in a community sample of elderly white women. Arthritis Rheum (2004) 2.32

Efficacy of continued alendronate for fractures in women with and without prevalent vertebral fracture: the FLEX trial. J Bone Miner Res (2010) 2.29

Effect of Mindfulness-Based Stress Reduction in rheumatoid arthritis patients. Arthritis Rheum (2007) 2.23

Treatment with once-weekly alendronate 70 mg compared with once-weekly risedronate 35 mg in women with postmenopausal osteoporosis: a randomized double-blind study. J Bone Miner Res (2004) 2.23

The risk of herpes zoster in patients with rheumatoid arthritis in the United States and the United Kingdom. Arthritis Rheum (2007) 2.16

Evaluating the value of repeat bone mineral density measurement and prediction of fractures in older women: the study of osteoporotic fractures. Arch Intern Med (2007) 2.10

Quantitative magnetic resonance imaging evaluation of knee osteoarthritis progression over two years and correlation with clinical symptoms and radiologic changes. Arthritis Rheum (2004) 2.01

Performance of risk indices for identifying low bone density in postmenopausal women. Mayo Clin Proc (2002) 1.97

Prevalence of rheumatoid arthritis in persons 60 years of age and older in the United States: effect of different methods of case classification. Arthritis Rheum (2003) 1.93

Randomized trial of effect of alendronate continuation versus discontinuation in women with low BMD: results from the Fracture Intervention Trial long-term extension. J Bone Miner Res (2004) 1.93

Circulating 25-hydroxyvitamin D levels and frailty status in older women. J Clin Endocrinol Metab (2010) 1.93

Objective physical activity measurement in the osteoarthritis initiative: Are guidelines being met? Arthritis Rheum (2011) 1.81

Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity. Ann Rheum Dis (2010) 1.76

Prevalence of hip symptoms and radiographic and symptomatic hip osteoarthritis in African Americans and Caucasians: the Johnston County Osteoarthritis Project. J Rheumatol (2009) 1.75

Back pain exacerbations and lost productive time costs in United States workers. Spine (Phila Pa 1976) (2006) 1.72

Psychological interventions for rheumatoid arthritis: a meta-analysis of randomized controlled trials. Arthritis Rheum (2002) 1.55

Surgical menopause and nonvertebral fracture risk among older US women. Menopause (2012) 1.52

Ethnic and sex differences in serum levels of cartilage oligomeric matrix protein: the Johnston County Osteoarthritis Project. Arthritis Rheum (2003) 1.41

Racial differences in rate of decline in bone mass in older men: the Baltimore men's osteoporosis study. J Bone Miner Res (2005) 1.40

Serum hyaluronan levels and radiographic knee and hip osteoarthritis in African Americans and Caucasians in the Johnston County Osteoarthritis Project. Arthritis Rheum (2005) 1.39

Risk factors for a first-incident radiographic vertebral fracture in women > or = 65 years of age: the study of osteoporotic fractures. J Bone Miner Res (2004) 1.38

Very low prevalence of hip osteoarthritis among Chinese elderly in Beijing, China, compared with whites in the United States: the Beijing osteoarthritis study. Arthritis Rheum (2002) 1.36

Assessing physical activity in persons with knee osteoarthritis using accelerometers: data from the osteoarthritis initiative. Arthritis Care Res (Hoboken) (2010) 1.30

Racial differences in bone mineral density in older men. J Bone Miner Res (2003) 1.30

Pins and plaster aren't enough: a call for the evaluation and treatment of patients with osteoporotic fractures. J Clin Endocrinol Metab (2003) 1.30

Higher risk of multiple falls among elderly women who lose visual acuity. Ophthalmology (2004) 1.27

Characterization of individual radiographic features of hip osteoarthritis in African American and White women and men: the Johnston County Osteoarthritis Project. Arthritis Care Res (Hoboken) (2010) 1.25

Body mass index is positively associated with bone mineral density in US older adults. Arch Osteoporos (2014) 1.21

Quality of osteoarthritis management and the need for reform in the US. Arthritis Care Res (Hoboken) (2010) 1.17

OMERACT/OARSI initiative to define states of severity and indication for joint replacement in hip and knee osteoarthritis. J Rheumatol (2007) 1.16

Pretreatment levels of bone turnover and the antifracture efficacy of alendronate: the fracture intervention trial. J Bone Miner Res (2005) 1.16

Height loss in older women: risk of hip fracture and mortality independent of vertebral fractures. J Bone Miner Res (2012) 1.15

Indirect comparison of tocilizumab and other biologic agents in patients with rheumatoid arthritis and inadequate response to disease-modifying antirheumatic drugs. Semin Arthritis Rheum (2010) 1.15

OARSI/OMERACT initiative to define states of severity and indication for joint replacement in hip and knee osteoarthritis. An OMERACT 10 Special Interest Group. J Rheumatol (2011) 1.14

Glaucoma risk and the consumption of fruits and vegetables among older women in the study of osteoporotic fractures. Am J Ophthalmol (2008) 1.13

FRAX and risk of vertebral fractures: the fracture intervention trial. J Bone Miner Res (2009) 1.12

Genetic variation in candidate osteoporosis genes, bone mineral density, and fracture risk: the study of osteoporotic fractures. Calcif Tissue Int (2008) 1.08

Significance of preradiographic magnetic resonance imaging lesions in persons at increased risk of knee osteoarthritis. Arthritis Rheumatol (2014) 1.07

Binocular visual-field loss increases the risk of future falls in older white women. J Am Geriatr Soc (2007) 1.06

Safety of abatacept administered intravenously in treatment of rheumatoid arthritis: integrated analyses of up to 8 years of treatment from the abatacept clinical trial program. J Rheumatol (2013) 1.04

Health of community-dwelling adults with mobility limitations in the United States: incidence of secondary health conditions. Part II. Arch Phys Med Rehabil (2008) 1.04

Gastrointestinal side effects in postmenopausal women using osteoporosis therapy: 1-year findings in the POSSIBLE US study. Curr Med Res Opin (2010) 1.02

Obesity and other modifiable factors for physical inactivity measured by accelerometer in adults with knee osteoarthritis. Arthritis Care Res (Hoboken) (2013) 1.02

Defining incident radiographic hip osteoarthritis for epidemiologic studies in women. Arthritis Rheum (2009) 1.02

Hearing sensitivity and the risk of incident falls and fracture in older women: the study of osteoporotic fractures. Ann Epidemiol (2004) 1.01

Caregiving intensity and change in physical functioning over a 2-year period: results of the caregiver-study of osteoporotic fractures. Am J Epidemiol (2009) 1.01

Meta-analysis of the efficacy of alendronate for the prevention of hip fractures in postmenopausal women. Osteoporos Int (2004) 1.00

A case-control study of serum tocopherol levels and the alpha- to gamma-tocopherol ratio in radiographic knee osteoarthritis: the Johnston County Osteoarthritis Project. Am J Epidemiol (2004) 0.99

Pain exacerbation as a major source of lost productive time in US workers with arthritis. Arthritis Rheum (2005) 0.99

Health of community-dwelling adults with mobility limitations in the United States: prevalent health conditions. Part I. Arch Phys Med Rehabil (2008) 0.99

Caregiving, metabolic syndrome indicators, and 1-year decline in walking speed: results of Caregiver-SOF. J Gerontol A Biol Sci Med Sci (2010) 0.98

Infections requiring hospitalization in the abatacept clinical development program: an epidemiological assessment. Arthritis Res Ther (2010) 0.97

Drug Insight: choosing a drug treatment strategy for women with osteoporosis-an evidence--based clinical perspective. Nat Clin Pract Rheumatol (2008) 0.97

Successful skeletal aging: a marker of low fracture risk and longevity. The Study of Osteoporotic Fractures (SOF). J Bone Miner Res (2009) 0.97

Impact of age-related macular degeneration on vision-specific quality of life: Follow-up from the 10-year and 15-year visits of the Study of Osteoporotic Fractures. Am J Ophthalmol (2010) 0.97

Association of the G-174C variant in the interleukin-6 promoter region with bone loss and fracture risk in older women. J Bone Miner Res (2004) 0.96

Suggested guidelines for evaluation and treatment of glucocorticoid-induced osteoporosis for the Department of Veterans Affairs. Arch Intern Med (2003) 0.96

Classification algorithms for hip fracture prediction based on recursive partitioning methods. Med Decis Making (2004) 0.96

Health economics in the field of osteoarthritis: an expert's consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Semin Arthritis Rheum (2013) 0.95

Novel methods to evaluate fracture risk models. J Bone Miner Res (2011) 0.95

Inflammatory markers and risk of hip fracture in older white women: the study of osteoporotic fractures. J Bone Miner Res (2014) 0.95

Relationship of blood lead levels to incident nonspine fractures and falls in older women: the study of osteoporotic fractures. J Bone Miner Res (2008) 0.95

New treatments for osteoarthritis. Curr Opin Rheumatol (2013) 0.94

Concomitant therapy: an outcome variable for musculoskeletal disorders? Part 2: total joint replacement in osteoarthritis trials. J Rheumatol (2005) 0.92

Gene expression profiling in peripheral blood mononuclear cells from lupus patients with active and inactive disease. Clin Immunol (2004) 0.91

Effect of alendronate for reducing fracture by FRAX score and femoral neck bone mineral density: the Fracture Intervention Trial. J Bone Miner Res (2012) 0.91

Self-ratings of health and change in walking speed over 2 years: results from the caregiver-study of osteoporotic fractures. Am J Epidemiol (2011) 0.90

Racial differences in the prevalence of vertebral fractures in older men: the Baltimore Men's Osteoporosis Study. Osteoporos Int (2005) 0.90

Visual field loss and risk of fractures in older women. J Am Geriatr Soc (2009) 0.89

Controversies in COX-2 selective inhibition. J Rheumatol (2002) 0.86

The association of consumption of fruits/vegetables with decreased risk of glaucoma among older African-American women in the study of osteoporotic fractures. Am J Ophthalmol (2012) 0.86

Efficacy and safety of naproxcinod in patients with osteoarthritis of the knee: a 53-week prospective randomized multicenter study. Semin Arthritis Rheum (2010) 0.86

The risk of cardiovascular thrombotic events with selective cyclooxygenase-2 inhibitors. Arthritis Rheum (2002) 0.85

Smoking, smoking cessation, and disease activity in a large cohort of patients with rheumatoid arthritis. J Rheumatol (2012) 0.84

Alendronic acid produces greater effects than risedronic acid on bone density and turnover in postmenopausal women with osteoporosis : results of FACTS -international. Clin Drug Investig (2006) 0.84

Racial and ethnic differences in physical activity guidelines attainment among people at high risk of or having knee osteoarthritis. Arthritis Care Res (Hoboken) (2013) 0.84

Association of blood lead concentrations with mortality in older women: a prospective cohort study. Environ Health (2009) 0.84

Genetics of osteoarthritis. Curr Rheumatol Rep (2004) 0.84

COX-2-selective inhibitors in the treatment of arthritis. Cleve Clin J Med (2002) 0.84

Estrogen receptor alpha and matrix metalloproteinase 2 polymorphisms and age-related maculopathy in older women. Am J Epidemiol (2008) 0.84

The association of smoking and alcohol use with age-related macular degeneration in the oldest old: the Study of Osteoporotic Fractures. Am J Ophthalmol (2009) 0.84

Reliability and validity of abbreviated surveys derived from the National Eye Institute Visual Function Questionnaire: the study of osteoporotic fractures. Am J Ophthalmol (2010) 0.82

How do people with knee osteoarthritis use osteoarthritis pain medications and does this change over time? Data from the Osteoarthritis Initiative. Arthritis Res Ther (2013) 0.81

Association analysis of BMD-associated SNPs with knee osteoarthritis. J Bone Miner Res (2014) 0.81